Compile Data Set for Download or QSAR
maximum 50k data
Found 47 Enz. Inhib. hit(s) with all data for entry = 50010549
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096172(1-Bromo-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5...)
Affinity DataKi:  2nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096166(1-Benzyloxy-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo...)
Affinity DataKi:  9nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096165(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  15nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096169(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  20nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096170(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  30nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096167(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  40nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096164(1,3-Dichloro-4-[2-(8-hydroxy-7,8-dihydro-6H-imidaz...)
Affinity DataKi:  50nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096171(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  90nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096175(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  220nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096168(1-Benzyloxy-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo...)
Affinity DataKi:  300nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096162(1,3-Dichloro-4-[2-(8-hydroxy-7,8-dihydro-6H-imidaz...)
Affinity DataKi:  300nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50087332(2-Benzyl-6-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5-d...)
Affinity DataKi:  410nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096157(1,3-Dichloro-4-[2-(8-hydroxy-7,8-dihydro-6H-imidaz...)
Affinity DataKi:  500nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50087377(3-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  500nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096174(1-Bromo-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5...)
Affinity DataKi:  530nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096159(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  720nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096177(6-Bromo-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5...)
Affinity DataKi:  960nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096174(1-Bromo-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5...)
Affinity DataKi:  1.00E+3nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096178(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  1.30E+3nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096173(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  1.80E+3nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096163(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  2.30E+3nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096176(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  2.40E+3nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096160(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  2.70E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50003602((2R,3S,5R)-2-((R)-8-Hydroxy-7,8-dihydro-6H-imidazo...)
Affinity DataKi:  3.00E+3nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096178(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  3.40E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096163(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  3.70E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096161(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  3.80E+3nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096158(6-Bromo-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5...)
Affinity DataKi:  4.40E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096159(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  5.00E+3nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096168(1-Benzyloxy-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096161(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096175(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096172(1-Bromo-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096171(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096170(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096167(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096157(1,3-Dichloro-4-[2-(8-hydroxy-7,8-dihydro-6H-imidaz...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096162(1,3-Dichloro-4-[2-(8-hydroxy-7,8-dihydro-6H-imidaz...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096166(1-Benzyloxy-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096165(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096164(1,3-Dichloro-4-[2-(8-hydroxy-7,8-dihydro-6H-imidaz...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096177(6-Bromo-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096173(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096176(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi: >7.50E+3nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096158(6-Bromo-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5...)
Affinity DataKi:  1.40E+4nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAMP deaminase 3(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096160(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  3.50E+4nMAssay Description:Inhibition of recombinant human E-type adenylate deaminaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Bos taurus (bovine))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50096169(4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi: >1.00E+6nMAssay Description:Inhibition of Calf intestinal adenosine deaminase (ADA).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed